In the fields of tissue engineering and regenerative medicine, an increased interest and use of bioprinting technology is changing the way researchers are conducting investigations.
In the fields of tissue engineering and regenerative medicine, an increased interest and use of bioprinting technology is changing the way researchers are conducting investigations.
A vaccine is the ultimate goal in the fight against the coronavirus pandemic, but its arrival is likely at least a year off, with that aggressive timeline being called a moonshot by one pharmaceutical company.
At least one outside expert said the approach could present safety risks. Paul Knoepfler, a stem cell researcher at the University of California, Davis, said that patients with coronavirus can develop severe reactions where their immune systems go too far in attacking cells in their lungs, causing damaging inflammation. Other cell therapies tested in China are designed to dampen the immune response
Athersys Inc.: MultiStem Cell Therapy Is The Most Advanced And Tested Treatment For ARDS, And Thus COVID-19 Seeking Alpha
The Food and Drug Administration approved the dual immunotherapy of Opdivo and Yervoy for the treatment of patients with advanced hepatocellular carcinoma. Heres what you need to know. This is the only dual immunotherapy approved by the FDA in this setting of patients with HCC and was based on the results of the phase 1/2 CheckMate-040 trial
The COVID-19 pandemic has created a unique challenge for patients with myelodysplastic syndromes and acute myeloid leukemia, creating many questions that experts tried to answer in a recent webinar from The Aplastic Anemia and MDS International Foundation. The Aplastic Anemia and MDS International Foundation (AAMDSIF) recently hosted a webinar to address the questions of this patient population by connecting them with Dr. Gail J.
Regenerative medicine company Mesoblast (ASX: MSB) has received US Food and Drug Administration Investigational New Drug (IND) clearance for its remestemcel-L treatment to be used in COVID-19 patients presenting with acute respiratory distress syndrome. According to Mesoblast chief medical officer Dr Fred Grossman, the FDA IND approval now enables US-based COVID-19 patients with poor prognosis to be treated with remestemcel-L under compassionate usage grounds and in a planned randomised controlled trial.
An article published in Experimental Biology and Medicine(Volume 245, Issue 6, March 2020)examines the safety of stem cell therapy for the treatment of colon cancer.The study, led by Dr. J.
The coronavirus, otherwise known as COVID-19, has dramatically transformed the lives of people around the globe. It has decimated economies, overwhelmed health care systems and affected families in unimaginable ways. However, in spite of the havoc that it has caused, COVID-19 has furthered our understanding of pandemic control beyond anything that we've known before
Survey aims to shed light on any misconceptions so that public agencies can address them. Two University of Miami researchers are investigating how much people truly know about COVID-19and whether they would be willing to take a drug to prevent themselves from getting the disease, if one existed. Dr
Recent Comments